From signal to alert : A cluster of exposures to counterfeit alprazolam tablets containing five novel benzodiazepines
Abstract Objective To illustrate the toxicosurveillance role of the Emerging Drugs Network of Australia – Victoria (EDNAV) project in informing timely harm minimisation interventions. Methods Utilisation of an ethics approved clinical registry storing de‐identified clinical and analytical data on Victorian ED illicit drug‐related presentations. Results In April 2022, six adults presented to hospital with varying levels of sedation, following the use of counterfeit benzodiazepines. Comprehensive toxicological analysis identified five separate novel benzodiazepines within blood samples from each patient. A public ‘Drug Alert’ was subsequently issued, and local emergency physicians were notified. Conclusion Toxicosurveillance projects, such as EDNAV, are critical to the continued monitoring and reporting of illicit substance use in the community..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Emergency Medicine Australasia - 35(2023), 1, Seite 165-167 |
| Beteiligte Personen: |
Syrjanen, Rebekka [VerfasserIn] |
|---|
| Anmerkungen: |
© 2023 Australasian College for Emergency Medicine |
|---|
| Umfang: |
3 |
|---|
| doi: |
10.1111/1742-6723.14108 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY015617874 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY015617874 | ||
| 003 | DE-627 | ||
| 005 | 20231111153841.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231111s2023 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/1742-6723.14108 |2 doi | |
| 028 | 5 | 2 | |a 2023-11-11_EMM_2023_35_1.zip.xml |
| 035 | |a (DE-627)WLY015617874 | ||
| 035 | |a (WILEY)EMM14108 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Syrjanen, Rebekka |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a From signal to alert |b A cluster of exposures to counterfeit alprazolam tablets containing five novel benzodiazepines |
| 264 | 1 | |c 2023 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2023 Australasian College for Emergency Medicine | ||
| 520 | |a Abstract Objective To illustrate the toxicosurveillance role of the Emerging Drugs Network of Australia – Victoria (EDNAV) project in informing timely harm minimisation interventions. Methods Utilisation of an ethics approved clinical registry storing de‐identified clinical and analytical data on Victorian ED illicit drug‐related presentations. Results In April 2022, six adults presented to hospital with varying levels of sedation, following the use of counterfeit benzodiazepines. Comprehensive toxicological analysis identified five separate novel benzodiazepines within blood samples from each patient. A public ‘Drug Alert’ was subsequently issued, and local emergency physicians were notified. Conclusion Toxicosurveillance projects, such as EDNAV, are critical to the continued monitoring and reporting of illicit substance use in the community. | ||
| 700 | 1 | |a Schumann, Jennifer |4 aut | |
| 700 | 1 | |a Hodgson, Sarah E |4 aut | |
| 700 | 1 | |a Abouchedid, Rachelle |4 aut | |
| 700 | 1 | |a Rotella, Joe‐Anthony |4 aut | |
| 700 | 1 | |a Graudins, Andis |4 aut | |
| 700 | 1 | |a Greene, Shaun L |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Emergency Medicine Australasia |g 35(2023), 1, Seite 165-167 |w (DE-627)WLY005315107 |x 17426723 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2023 |g number:1 |g pages:165-167 |g extent:3 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2023 |e 1 |h 165-167 |g 3 | ||